Kerendia

Medicinal product

(Invented) name

Kerendia

Active substance (s)

Finerenonas

Strength

20 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C03DA05, finerenone

Marketing authorisation holder

Abacus Medicine A/S, Danija

Date of authorisation

2026-06-08

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

CR-Lygiagretus platinimas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Finerenonas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
121701	107810	1107810	lizdinė plokštelė	N28		Receptinis	EU/1/21/1616/007	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-06-08	Registruotas